Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary

Published:2019-11 Issue:11 Volume:15 Page:603-606
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Shapiro Charles L.¹,Yarom Noam²,Peterson Douglas E.³,Bohlke Kari⁴,Saunders Deborah P.⁵

Affiliation:

1. Icahn School of Medicine at Mount Sinai, New York, NY

2. Tel Hashomer and Tel Aviv University, Tel Aviv, Israel

3. UConn Health, University of Connecticut Health Center, Farmington, CT

4. American Society of Clinical Oncology, Alexandria, VA

5. Health Sciences North, Northern Ontario School of Medicine, Sudbury, Ontario, Canada

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology(nursing),Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JOP.19.00384

Reference20 articles.

1. Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015

2. American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update

3. Risk factors influencing the duration of treatment with bisphosphonates until occurrence of an osteonecrosis of the jaw in 963 cancer patients

4. Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer

5. Bisphosphonate (zoledronic acid)-induced osteonecrosis of the jaw

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The trend of dental check-up and prevalence of dental complications following the use of bone modifying agents in patients with metastatic breast and prostate cancer: analysis of data from the Korean National Health Insurance Service;BMC Health Services Research;2024-04-02

2. The use of bone-modifying agents in multiple myeloma;Blood Reviews;2023-01

3. Reply to Fusco et al;JCO Oncology Practice;2020-03

4. Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary;JCO Oncology Practice;2020-03

5. Decreased Osteogenic Ability of Periodontal Ligament Stem Cells Leading to Impaired Periodontal Tissue Repair in BRONJ Patients;Stem Cells and Development;2020-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3